/DENKF

DENKF Stock - Denka Company Limited

Q: What is the analyst price target for DENKF?

Analyst price target information is not currently available for DENKF.

Q: What is DENKF's market cap?

Market capitalization information is not currently available for DENKF.

Basic Materials|Chemicals|OTC

$18.24+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $20.06

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for DENKF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.14

52W High$18.24

52W Low$17.75

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$400.25B	$389.26B	$407.56B	$384.85B	$354.39B
Gross Profit	$84.59B	$82.50B	$102.34B	$107.17B	$100.19B
Gross Margin	21.1%	21.2%	25.1%	27.8%	28.3%
Operating Income	$14.41B	$13.38B	$32.32B	$40.12B	$34.73B
Net Income	$-12,300,000,000	$11.95B	$12.77B	$26.01B	$22.79B
Net Margin	-3.1%	3.1%	3.1%	6.8%	6.4%
EPS	$-142.73	$138.61	$148.07	$301.67	$264.23

Company Overview

Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division supplies influenza vaccines; manufactures rapid diagnostic testing kits for detecting antigens of infectious diseases, such as the novel coronavirus; and delivers macromolecular sodium hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural corrugated pipes. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs and hairpieces, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.

Visit Website

Earnings History & Surprises

DENKF

Beat Rate

47%

Last 17 quarters

Avg Surprise

-63.0%

EPS vs Estimate

Beats / Misses

8/9

Last 12 quarters

Latest EPS

$-0.00

Q4 2025

EPS Surprise History

Q1 24

-184.8%

$-0.25vs$0.29

Q2 24

-3.6%

$0.64vs$0.66

Q3 24

+50.3%

$0.16vs$0.11

Q4 24

-41.0%

$0.09vs$0.15

Q1 25

-136.1%

$-0.06vs$0.16

Q2 25

-720.5%

$-1.19vs$0.19

Q3 25

+231.7%

$0.40vs$0.12

Q4 25

-100.2%

$-0.00vs$0.29

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 11, 2026	—	—	—	—
Q1 2026	Feb 6, 2026	—	—	—	—
Q4 2025	Nov 10, 2025	$0.29	$-0.00	-100.2%	✗ MISS
Q3 2025	Aug 7, 2025	$0.12	$0.40	+231.7%	✓ BEAT
Q2 2025	May 13, 2025	$0.19	$-1.19	-720.5%	✗ MISS
Q1 2025	Feb 5, 2025	$0.16	$-0.06	-136.1%	✗ MISS
Q4 2024	Nov 8, 2024	$0.15	$0.09	-41.0%	✗ MISS
Q3 2024	Aug 7, 2024	$0.11	$0.16	+50.3%	✓ BEAT
Q2 2024	May 10, 2024	$0.66	$0.64	-3.6%	✗ MISS
Q1 2024	Feb 7, 2024	$0.29	$-0.25	-184.8%	✗ MISS
Q3 2023	Sep 30, 2023	$0.29	$0.33	+12.9%	✓ BEAT
Q2 2023	Jun 30, 2023	—	$0.18	—	—
Q1 2023	Mar 31, 2023	$0.20	$0.34	+74.3%	✓ BEAT
Q1 2023	Feb 6, 2023	$39.43	$-63.61	-261.3%	✗ MISS
Q4 2022	Nov 7, 2022	$70.04	$115.85	+65.4%	✓ BEAT
Q3 2022	Aug 4, 2022	$44.36	$50.30	+13.4%	✓ BEAT
Q2 2022	May 10, 2022	$67.39	$35.96	-46.6%	✗ MISS
Q1 2022	Feb 6, 2022	$90.09	$56.42	-37.4%	✗ MISS
Q4 2021	Nov 7, 2021	$131.04	$137.88	+5.2%	✓ BEAT
Q3 2021	Aug 5, 2021	$66.63	$71.41	+7.2%	✓ BEAT